Memantine Hydrochloride 28 mg/1

Memantine hydrochloride 28 mg/1 is an extended-release capsule used to manage moderate to severe Alzheimer's disease symptoms. This medication works by regulating glutamate activity in the brain, potentially improving cognitive function and daily living activities.

Memantine hydrochloride is primarily used to treat moderate to severe Alzheimer's disease. It is designed to slow the progression of symptoms by modulating glutamate, a neurotransmitter involved in brain function. This medication is often prescribed as part of a comprehensive treatment plan to help maintain cognitive abilities and independence.

Common effects of memantine hydrochloride may include dizziness, headache, and constipation. Some users might experience confusion or fatigue. These effects vary individually and typically subside as the body adjusts to the medication. Always consult a healthcare provider for personalized advice.

Memantine hydrochloride should be handled with care, especially for individuals with a history of seizures or severe liver or kidney disease. It is important to follow the prescribed dosage and administration instructions. Store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Memantine hydrochloride may interact with other medications, including certain antidepressants, anticonvulsants, and drugs that affect kidney function. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be minimized while using this medication.